Abstract 231 Table 1
Endpoints
HTx Patients with PAD (n=26)
No PAD (n=322)
P-Value
5 Year Survival
69.2%
81.4%
0.220
5 Year Freedom from CAV
88.5%
84.5%
0.557
5 Year Freedom from NF-MACE
73.1%
78.3%
0.673